Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-27T19:46:42.014Z Has data issue: false hasContentIssue false
  • English
  • Français

Procalcitonin as a marker of bacterial infection in children undergoing cardiac surgery with cardiopulmonary bypass

Published online by Cambridge University Press:  09 March 2011

Pierre-Emmanuel Séguéla ,
Nicolas Joram ,
Bénédicte Romefort ,
Céline Manteau ,
Jean-Luc Orsonneau ,
Bernard Branger ,
Véronique Gournay ,
Jean-Christophe Rozé  and
Christèle Gras-Le Guen
Pierre-Emmanuel Séguéla*
Affiliation:
Pediatric Cardiology Unit, Nantes University Hospital, Nantes, France
Nicolas Joram
Affiliation:
Pediatric Intensive Care Unit, Nantes University Hospital, Nantes, France
Bénédicte Romefort
Affiliation:
Pediatric Intensive Care Unit, Nantes University Hospital, Nantes, France
Céline Manteau
Affiliation:
Pediatric Department, Nantes University Hospital, Nantes, France
Jean-Luc Orsonneau
Affiliation:
Biochemistry Laboratory, Nantes University Hospital, Nantes, France
Bernard Branger
Affiliation:
Réseau Sécurité Naissance Naître Ensemble des Pays de la Loire, Nantes University Hospital, Nantes, France
Véronique Gournay
Affiliation:
Pediatric Cardiology Unit, Nantes University Hospital, Nantes, France
Jean-Christophe Rozé
Affiliation:
Pediatric Intensive Care Unit, Nantes University Hospital, Nantes, France
Christèle Gras-Le Guen
Affiliation:
Pediatric Intensive Care Unit, Nantes University Hospital, Nantes, France
*
Correspondence to: Dr P.-E. Séguéla, Pediatric Cardiology Unit, Children's Hospital, Toulouse University Hospital, 330 Avenue de Grande-Bretagne, 31059 Toulouse Cedex 9, France. Tel: 0033 534557459; Fax: 003 534558663; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Owing to systemic inflammatory response syndrome, the diagnosis of post-operative infection after cardiopulmonary bypass is difficult to assess in children with the usual clinical and biological tools. Procalcitonin could be informative in this context.

Methods

Retrospective study in a paediatric intensive care unit. Blood samples were collected as soon as infection was clinically suspected and a second assay was performed 24 hours later. Using referenced criteria, children were retrospectively classified into two groups: infected and non-infected.

Results

Out of the 95 children included, 14 were infected. Before the third post-operative day, procalcitonin median concentration was significantly higher in the infected group than in the non-infected group – 20.24 nanograms per millilitre with a 25th and 75th interquartile of 15.52–35.71 versus 0.72 nanograms per millilitre with a 25th and 75th interquartile of 0.28 to 5.44 (p = 0.008). The area under the receiver operating characteristic curve was 0.89 with 95% confidence intervals from 0.80 to 0.97. The best cut-off value to differentiate infected children from healthy children was 13 nanograms per millilitre with 100% sensitivity – 95% confidence intervals from 51 to 100 – and 85% specificity – 95% confidence intervals from 72 to 91. After the third post-operative day, procalcitonin was not significantly higher in infected children – 2 nanograms per millilitre with a 25th and 75th interquartile of 0.18 to 12.42 versus 0.37 nanograms per millilitre with a 25th and 75th interquartile of 0.24 to 1.32 (p = 0.26). The area under the receiver operating characteristic curve was 0.62 with 95% confidence intervals from 0.47 to 0.77. A procalcitonin value of 0.38 nanograms per millilitre provided a sensitivity of 70% with 95% confidence intervals from 39 to 89 for a specificity of 52% with 95% confidence intervals from 34 to 68. After the third post-operative day, a second assay at a 24-hour interval can improve the sensitivity of the test.

Conclusions

Procalcitonin seems to be a discriminating marker of bacterial infection during the post-operative days following cardiopulmonary bypass in children.

Keywords

Systemic inflammatory response syndromecardiac surgerybiological marker
Type
Original Articles
Information
Cardiology in the Young , Volume 21 , Issue 4 , 12 July 2011 , pp. 392 - 399
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Cremer, J, Martin, M, Redl, H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61: 1714–1720.CrossRefGoogle ScholarPubMed
2.Ferrière, F. Procalcitonin, a new marker for bacterial infections. Ann Biol Clin 2000; 58: 49–59.Google ScholarPubMed
3.Assicot, M, Gendrel, D, Carsin, H, Raymond, J, Guilbaud, J, Bohuon, C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515–518.CrossRefGoogle ScholarPubMed
4.Dandona, P, Nix, D, Wilson, MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605–1608.Google ScholarPubMed
5.Gendrel, D, Bohuon, C. Procalcitonin in pediatrics for differentiation of bacterial and viral infections. Intensive Care Med 2000; 26 (Suppl 2): S178–S181.CrossRefGoogle Scholar
6.Gendrel, D, Assicot, M, Raymond, J, et al. Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 1996; 128: 570–573.CrossRefGoogle ScholarPubMed
7.Gendrel, D, Bohuon, C. Procalcitonin, a marker of bacterial infection. Infection 1997; 25: 133–134.CrossRefGoogle ScholarPubMed
8.Gendrel, D, Raymond, J, Assicot, M, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997; 24: 1240–1242.CrossRefGoogle ScholarPubMed
9.Gendrel, D, Bohuon, C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19: 679–687.CrossRefGoogle ScholarPubMed
10.Hammer, S, Loeff, M, Reichenspurner, H, et al. Effect of cardiopulmonary bypass on myocardial function, damage and inflammation after cardiac surgery in newborns and children. Thorac Cardiovasc Surg 2001; 49: 349–354.CrossRefGoogle ScholarPubMed
11.Beghetti, M, Rimensberger, PC, Kalangos, A, Habre, W, Gervaix, A. Kinetics of procalcitonin, interleukin 6 and C-reactive protein after cardiopulmonary-bypass in children. Cardiol Young 2003; 13: 161–167.CrossRefGoogle ScholarPubMed
12.Arkader, R, Troster, EJ, Abellan, DM, et al. Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients. J Cardiothorac Vasc Anesth 2004; 18: 160–165.CrossRefGoogle ScholarPubMed
13.Hammer, S, Fuchs, AT, Rinker, C, Daebritz, S, Kozlik-Feldmann, R, Netz, H. Interleukin-6 and procalcitonin in serum of children undergoing cardiac surgery with cardiopulmonary bypass. Acta Cardiol 2004; 59: 624–629.CrossRefGoogle ScholarPubMed
14.Michalik, DE, Duncan, BW, Mee, RB, et al. Quantitative analysis of procalcitonin after pediatric cardiothoracic surgery. Cardiol Young 2006; 16: 48–53.CrossRefGoogle ScholarPubMed
15.McMaster, P, Park, DY, Shann, F, et al. Procalcitonin versus C-reactive protein and immature-to-total neutrophil ratio as markers of infection after cardiopulmonary bypass in children. Pediatr Crit Care Med 2009; 10: 217–221.CrossRefGoogle ScholarPubMed
16.Celebi, S, Koner, O, Menda, F, et al. Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery. Intensive Care Med 2006; 32: 881–887.CrossRefGoogle ScholarPubMed
17.Arkader, R, Troster, EJ, Lopes, MR, et al. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child 2006; 91: 117–120.CrossRefGoogle ScholarPubMed
18.Goldstein, B, Giroir, B, Randolph, A, International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: 2–8.CrossRefGoogle ScholarPubMed
19.Langley, JM, Bradley, JS. Defining pneumonia in critically ill infants and children. Pediatr Crit Care Med 2005; 6 (3 Suppl): S9–S13.CrossRefGoogle ScholarPubMed
20.Upperman, JS, Sheridan, RL, Marshall, J. Pediatric surgical site and soft tissue infections. Pediatr Crit Care Med 2005; 6 (3 Suppl): S36–S41.CrossRefGoogle ScholarPubMed
21.Langley, JM. Defining urinary tract infection in the critically ill child. Pediatr Crit Care Med 2005; 6 (3 Suppl): S25–S29.CrossRefGoogle ScholarPubMed
22.El Oakley, RM, Wright, JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996; 61: 1030–1036.CrossRefGoogle ScholarPubMed
23.Bone, RC, Balk, RA, Cerra, FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644–1655.Google ScholarPubMed
24.Mehta, PA, Cunningham, CK, Colella, CB, Alferis, G, Weiner, LB. Risk factors for sternal wound and other infections in pediatric cardiac surgery patients. Pediatr Infect Dis J 2000; 19: 1000–1004.CrossRefGoogle ScholarPubMed
25.Valera, M, Scolfaro, C, Cappello, N, et al. Nosocomial infections in pediatric cardiac surgery, Italy. Infect Control Hosp Epidemiol 2001; 22: 771–775.CrossRefGoogle ScholarPubMed
26.Levy, I, Ovadia, B, Erez, E, et al. Nosocomial infections after cardiac surgery in infants and children: incidence and risk factors. J Hosp Infect 2003; 53: 111–116.CrossRefGoogle ScholarPubMed
27.Sarvikivi, E, Lyytikäinen, O, Nieminen, H, Sairanen, H, Saxén, H. Nosocomial infections after pediatric cardiac surgery. Am J Infect Control 2008; 36: 564–569.CrossRefGoogle ScholarPubMed
28.Grisaru-Soen, G, Paret, G, Yahav, D, Boyko, V, Lerner-Geva, L. Nosocomial infections in pediatric cardiovascular surgery patients: a 4-year survey. Pediatr Crit Care Med 2009; 10: 202–206.CrossRefGoogle ScholarPubMed